Op-Ed: Bans on Life-Saving Harm Reduction Products Leads to More Problems

Taxpayers Protection Alliance

February 18, 2022

This was originally published by Townhall on Friday, February 18, 2022.

Right before the world was transformed by the COVID-19 pandemic, the United States was seemingly dealing with another so-called “epidemic” of vaping-related lung injuries. As quickly as this vaping “epidemic” came into attention, it dissipated, with the Centers for Disease Control and Prevention (CDC) reporting in February 2020 that cases were declining “after sharply increasing in August 2019 and peaking September.”

Unfortunately for adult users of tobacco harm reduction products, policymakers – armed with misinformation from anti-tobacco and vaping organizations – blamed all vapes and moved to restrict the sales of flavored vapor products. The CDC would eventually determine that most of the vaping-related lung injuries were attributed to black market products containing tetrahydrocannabinol (THC). Not that it mattered. As of February 2022, New Jersey, New York, and Rhode Island have banned flavored vapor products, Massachusetts has banned both flavored tobacco and vapor products, and voters in California will decide in November if the Golden State too will join Massachusetts.

While the spat of lung injuries was touted to justify statewide bans, anti-tobacco organizations had been actively pushing localized flavor bans, which may have led to more increases of vaping-related lung injuries.